Biotron Statistics

Total Valuation

Biotron has a market cap or net worth of AUD 3.32 million. The enterprise value is 2.44 million.

Market Cap	3.32M
Enterprise Value	2.44M

Important Dates

The last earnings date was Thursday, May 29, 2025.

Earnings Date	May 29, 2025
Ex-Dividend Date	n/a

Share Statistics

Biotron has 1.33 billion shares outstanding. The number of shares has increased by 0.11% in one year.

Current Share Class	1.33B
Shares Outstanding	1.33B
Shares Change (YoY)	+0.11%
Shares Change (QoQ)	+9.94%
Owned by Insiders (%)	7.05%
Owned by Institutions (%)	n/a
Float	1.13B

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.83
PB Ratio	7.23
P/TBV Ratio	7.23
P/FCF Ratio	18.55
P/OCF Ratio	18.23
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-1.72
EV / Sales	1.34
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	13.63

Financial Position

The company has a current ratio of 1.83

Current Ratio	1.83
Quick Ratio	1.75
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-94.80

Financial Efficiency

Return on equity (ROE) is -121.67% and return on invested capital (ROIC) is -76.25%.

Return on Equity (ROE)	-121.67%
Return on Assets (ROA)	-51.97%
Return on Invested Capital (ROIC)	-76.25%
Return on Capital Employed (ROCE)	-313.06%
Revenue Per Employee	604,832
Profits Per Employee	-472,029
Employee Count	3
Asset Turnover	1.05
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -95.99% in the last 52 weeks. The beta is -0.70, so Biotron's price volatility has been lower than the market average.

Beta (5Y)	-0.70
52-Week Price Change	-95.99%
50-Day Moving Average	0.00
200-Day Moving Average	0.01
Relative Strength Index (RSI)	39.85
Average Volume (20 Days)	617,512

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Biotron had revenue of AUD 1.81 million and -1.42 million in losses. Loss per share was -0.00.

Revenue	1.81M
Gross Profit	1.81M
Operating Income	-1.44M
Pretax Income	-1.42M
Net Income	-1.42M
EBITDA	-1.45M
EBIT	-1.44M
Loss Per Share	-0.00

Full Income Statement

Balance Sheet

The company has 878,881 in cash and n/a in debt, giving a net cash position of 878,881 or 0.00 per share.

Cash & Cash Equivalents	878,881
Total Debt	n/a
Net Cash	878,881
Net Cash Per Share	0.00
Equity (Book Value)	459,033
Book Value Per Share	0.00
Working Capital	417,925

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 181,990 and capital expenditures -3,071, giving a free cash flow of 178,919.

Operating Cash Flow	181,990
Capital Expenditures	-3,071
Free Cash Flow	178,919
FCF Per Share	0.00

Full Cash Flow Statement

Margins

Gross margin is 100.00%, with operating and profit margins of -79.20% and -78.04%.

Gross Margin	100.00%
Operating Margin	-79.20%
Pretax Margin	-78.04%
Profit Margin	-78.04%
EBITDA Margin	-79.90%
EBIT Margin	-79.20%
FCF Margin	9.86%

Dividends & Yields

Biotron does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.11%
Shareholder Yield	n/a
Earnings Yield	-42.68%
FCF Yield	5.39%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Biotron has an Altman Z-Score of -34.73. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-34.73
Piotroski F-Score	n/a